Trial of lurbinectedin for small cell lung cancer meets primary endpoint - Healio

Trial of lurbinectedin for small cell lung cancer meets primary endpoint  Healio

A phase 2 trial designed to evaluate the safety and efficacy of lurbinectedin for patients with relapsed small cell lung cancer met its primary endpoint of overall ...